Medico Remedies
MEDICONSE

Medico Remedies

₹44.270.93 (2.15%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
42.42
Today’s high
45.55
52 week low
30.22
52 week high
58.99
Open price
43.20
Previous close
43.34
Live volume
2,09,719
Lower circuit
34.68
Upper circuit
52.00

Fundamentals

Market Cap
₹361Cr
ROE
16.97%
P/E Ratio(TTM)
31.10
EPS(TTM)
1.40
P/B Ratio
5.40
Dividend Yield
0.00%
Industry P/E
44.11
Book Value
8.06
Debt to Equity
0.19
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹59.36
+9.20%
Profit (Cr)
₹2.87
+11.67%
015304560
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+45%
3Y CAGR+8%
Profit growthValue
1Y (TTM)+10%
3Y CAGR+28%

About

Medico Remedies Limited is a public company primarily operating in the pharmaceutical sector, dedicated to the development, manufacturing, and sale of pharmaceutical and nutraceutical products. The company's philosophy is to consistently follow the principles of transparency, accountability, and ethical business conduct to achieve excellence and enhance stakeholder value. A key objective is to create an inspirational work climate where talented employees are engaged in generating sustained value for the stakeholders. Its product range includes a variety of medicines for oral use like antihypertensives, antidiabetics, antibiotics, diuretics, antimalarials, and NSAIDS tablets for various treatments. In addition to oral medications, the company also produces external preparations such as creams and ointments, including anti-infectives, antifungals, and steroidal formulas. Reflecting its financial health, the company achieved a Net Profit After Tax of ₹829 Lakhs for the fiscal year under review.;
CEO/MD
Mr. Harshit Haresh Mehta
Founded in
1994
NSE symbol
MEDICO

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
61.38%
Retail And Others
38.59%
Foreign Institutions
0.03%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹858.30
-13.60 (1.56%)
L
    H
    4,987.4435.394.57
    ₹370.30
    -2.70 (0.72%)
    L
      H
      4,098.7385.6815.5
      ₹400.40
      +0.90 (0.23%)
      L
        H
        3,741.8741.755.13
        Orchid PharmaORCHPHARMA
        ₹712.60
        -6.65 (0.92%)
        L
          H
          3,650.51193.482.87
          2026
          12
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks